< Back to latest news & events

Event

The Business of Science Conference 2021

September 2021

Event date: 7th October 2021

HGF is sponsoring The Business of Science Conference 2021 on 7th October.

Science and the commercialisation of science continues to be fundamental to the economic growth of the UK and its economy. The Business of Science conference will be held in Birmingham in 2021 to highlight that this city and the wider region has a successful role in the development of ground-breaking science, innovation and invention.

HGF Partner Andy Camenisch will be speaking on ‘Is your IP fit for investment‘. Partners Dr Andrew Wells, Dr Chris Moore, Marie McMorrow and Senior Patent Attorney Dr Janine Swarbrick will also be attending the event.

Find out more

 

Attendees

Andrew
Wells

Marie
McMorrow

Andrew
Camenisch

Latest updates

Polymorphs: Clearing the Inventive Step Hurdle at the European Patent Office (EPO)

Polymorphic forms of active pharmaceutical ingredients (APIs) can represent commercially valuable compound subject matter and can be critical to providing necessary drug product characteristics and performance. However, patenting polymorphs is …

Read article

IQPC Global US Exchange

HGF are proud ‘Silver Plus’ sponsors of the IQPC Global US Exchange, at the Austin Marriot South, Texas. The IQPC Global US Exchange will be held at the Austin Marriot …

Read article

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

The Genetic Technology (Precision Breeding) Act 2023 could come into force as early as spring 2025. It empowers the Food Standards Agency (FSA) to create a new simplified regulatory pathway …

Read article

Court of Appeal Decision Upholds Invalidity of Patent Due to Amendment Identifying Embodiment as Outside the Scope of the Claims

In a case that highlights the challenges arising due to post-grant amendments, and in particular interpretation of the claims in view of the description, the Court of Appeal in Ensygnia …

Read article

UPC Court of Appeal clarifies approach for interpreting claims with “obvious” errors

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20 December 2024 Alexion Pharmaceuticals, Inc. v Amgen Technology …

Read article

IP Ingredients: Winter Case Law Review 2024

As the nights draw in and the frenzy to finish everything off before the holiday season reaches its peak, it’s time to take a break, grab your favourite hot beverage …

Read article
See all updates